Mvrix Co.,Ltd.

République de Corée

Commandez votre montre hebdomadaire Mvrix Co.,Ltd.
Quantité totale PI 28
Rang # Quantité totale PI 53 689
Note d'activité PI 2,6/5.0    42
Rang # Activité PI 17 623
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

11 1
0 0
15 1
0
 
Dernier brevet 2026 - Pharmaceutical composition conta...
Premier brevet 2017 - Pharmaceutical composition compr...
Dernière marque 2022 - MVRIX
Première marque 2022 - MVRIX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Pharmaceutical composition containing her2-binding lipid nanoparticles loaded with mrna encoding ...
Invention Pharmaceutical lipid nanoparticle composition with improved targeted delivery ability and safety....
Invention Method for producing botulinum toxin using soluble partner and intein. The present invention rela...
Invention Nanodisc comprising virus receptor and fc fragment, and antiviral use thereof. The present invent...
2024 Invention Nanodisc comprising angiotensin-converting enzyme 2 and fc fragment, and use thereof. The present...
Invention Nanodisc using dimer bonding. The present invention relates to a nanodisc manufactured by utilizi...
Invention Viral receptor bound with sialic acid compounds. Disclosed is a viral receptor that contains a s...
Invention Nanodiscs comprising fab fragments and fc fragments of antibody and antiviral use thereof. The pr...
2023 Invention Nanodisc comprising phosphatidylethanolamine phospholipid. The present invention relates to a nan...
Invention Polymer nanodiscs comprising angiotensin-converting enzyme 2 and antiviral use thereof. The prese...
Invention Nanodisc comprising membrane scaffold protein having fc region of antibody fused thereto. The pr...
Invention Nanodisc comprising membrane scaffold protein having fc region of antibody fused thereto. The pre...
Invention Nanodisc comprising angiotensin converting enzyme 2. The present invention relates to a nanodisc...
Invention Nanodisc comprising angiotensin converting enzyme 2 and antiviral use thereof. The present invent...
Invention Nanodisc comprising angiotensin converting enzyme 2. The present invention relates to a nanodisc ...
Invention Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein. The pre...
2022 P/S Pharmaceutical product research; pharmaceutical development; pharmaceutical research; medicine re...
P/S Pharmaceutical product research; pharmaceutical development business; pharmaceutical research; m...
Invention Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodi...
Invention Protein complex including botulinum toxin translocation domain and endolysin and antibacterial co...
2021 Invention Viral receptor bound with sialic acid compounds. Disclosed is a viral receptor that contains a si...
2020 Invention Method for safely producing botulinum neurotoxin. The present invention relates to a method for p...
Invention Nano-perforator having improved anti-viral activity. The present invention relates to improvemen...
Invention Tag protein for increasing water solubility and heat stability of target protein, and fusion prot...
2017 Invention Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious ...